Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

RNA and TCR Sequencing Shed Light on Mechanisms of Treg Suppression in a Murine Model of Acute GvHD

Juliane K. Lohmeyer, MD, Toshihito Hirai, MD PhD, Mustafa Turkoz, PhD, Natalie Koehler, PhD, Jeanette Baker, Stephane Buhler, PhD, Jean Villard, MD PhD, Xuhuai Ji, MD PhD, Federico Simonetta, MD PhD, Robert S. Negrin, MD

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-137220

Published: 2020

Journal Articles

Molecular Imaging of Chimeric Antigen Receptor T Cells By ICOS-Immunopet

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-136331

Published: 2020

Journal Articles

Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming

Federico Simonetta, MD PhD, Toshihito Hirai, MD PhD, Juliane K. Lohmeyer, MD, Kristina Maas-Bauer, MD, Maite Alvarez, PhD, Arielle S. Wenokur, Jeanette Baker, Amin Aalipour, PhD, Samuel Haile, PhD, Crystal L. Mackall, MD, Robert S. Negrin, MD

Blood (2019) 134 (Supplement_1): 867.

https://doi.org/10.1182/blood-2019-122515

Published: 2019

Journal Articles

iNKT Cell Stimulation with Liposomal Alpha/Gal/Cer Amplifies Proliferation of Adoptively Transferred Regulatory T Cells In Vivo and Reduces GvHD

Toshihito Hirai, MD PhD, Federico Simonetta, MD PhD, Kristina Maas-Bauer, MD, Melissa Mavers, MD PhD, Jeanette Baker, Robert S. Negrin, MD

Blood (2018) 132 (Supplement 1): 4519.

https://doi.org/10.1182/blood-2018-99-109836

Published: 2018

Journal Articles

Tracking T Cell Activation By OX40 Immuno-PET: A Novel Strategy for Imaging of Graft Versus Host Disease

Federico Simonetta, MD PhD, Israt S. Alam, PhD, Aaron T. Mayer, Surya Murty, Ophir Vermesh, MD PhD, Toshihito Hirai, MD PhD, Tomomi Nobashi, MD, Kenneth Lau, Sanjiv S. Gambhir, MD PhD, Robert S. Negrin, MD

Blood (2018) 132 (Supplement 1): 4527.

https://doi.org/10.1182/blood-2018-99-116483

Published: 2018

Journal Articles

Invariant Natural Killer T Cell Subsets Have Diverse Functions: iNKT2 and iNKT17 Protect from Graft-Versus-Host-Disease, Whereas iNKT1 Have Antitumor Potential

Kristina Maas-Bauer, MD, Federico Simonetta, MD PhD, Toshihito Hirai, MD PhD, Arielle Wenokur, Furqan Fazal, PhD, Neeraja Kambham, MD, Jessica Ribado, Melissa Mavers, MD PhD, Jeanette Baker, Ami S. Bhatt, MD PhD, Howard Y. Chang, MD PhD, Robert S. Negrin, MD

Blood (2018) 132 (Supplement 1): 475.

https://doi.org/10.1182/blood-2018-99-113673

Published: 2018

Journal Articles

IL-2 Plus IL-15 Leads to Enhanced Ex Vivo Expansion of Human Invariant Natural Killer T Cells

Melissa Mavers, MD, Federico Simonetta, MD PhD, Alexander W. Lee, Toshihito Hirai, MD PhD, Kristina Maas-Bauer, MD, Jeanette Baker, PhD, Maite Alvarez, PhD, Mustafa Turkoz, PhD, Everett H. Meyer, MD PhD, Robert S. Negrin, MD

Blood (2017) 130 (Supplement 1): 3199.

https://doi.org/10.1182/blood.V130.Suppl_1.3199.3199

Published: 2017

Journal Articles

Treatment of Donors with Liposomal Alpha-Galactosylceramide Results in the In Vivo Expansion of Invariant Natural Killer T Cells and Reduced Incidence of Acute Graft Versus Host Disease

Toshihito Hirai, MD PhD, Federico Simonetta, MD PhD, Jeanette Baker, PhD, Kristina Maas-Bauer, MD, Musutafa Turkoz, Maite Alvarez, PhD, Melissa Mavers, MD, Robert S. Negrin, MD

Blood (2017) 130 (Supplement 1): 1896.

https://doi.org/10.1182/blood.V130.Suppl_1.1896.1896

Published: 2017

Journal Articles

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Yves Chalandon, MD, Federico Simonetta, MD PhD, Carole Dantin, MSc, Aikaterini Koutsi, MD, Anne-Claire Mamez, MD, Yan Beauverd, MD, Olga Tsopra, MD, Audrey Simon, MD, Stijn Bex, MD, Caroline Stephan, MD, Juan Felipe Rodriguez Morales, MD, Karolina Polchlopek, MD, Marc Ansari, MD, Yordanka Tirefort, MD, Eddy Roosnek, PhD, Stavroula Masouridi-Levrat, MD

Blood (2016) 128 (22): 2204.

https://doi.org/10.1182/blood.V128.22.2204.2204

Published: 2016

Journal Articles

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

Federico Simonetta, MD PhD, Hélène Labussière-Wallet, MD, Maciej J Machaczka, MD, Flore Sicre de Fontbrune, MD, Michael Medinger, MD, Sylvain Chantepie, MD, Tony Marchand, MD, Stavroula Masouridi-Levrat, MD, Marie-Thérèse Rubio, MD PhD, Oumedaly Reman, MD, Nathalie Dhedin, MD, Loic Fouillard, MD, Olivier Lambotte, MD PhD, Lionel Galicier, MD, Paul Coppo, MD PhD, Jakob Passweg, MD, Ibrahim Yakoub-Agha, MD PhD, Regis Peffault De Latour, MD PhD, Yves Chalandon, MD

Blood (2016) 128 (22): 4617.

https://doi.org/10.1182/blood.V128.22.4617.4617

Published: 2016

Journal Articles

T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Federico Simonetta, MD PhD, Stavroula Masouridi-Levrat, MD, Yan Beauverd, MD, Olga Tsopra, MD, Yordanka Tirefort, MD, Caroline Stephan, MD, Karolina Polchlopek, MD, Riccardo Favale, MD, Carole Dantin, MSc, Marc Ansari, MD, Eddy Roosnek, PhD, Yves Chalandon

Blood (2015) 126 (23): 3204.

https://doi.org/10.1182/blood.V126.23.3204.3204

Published: 2015

NARROW

RNA and TCR Sequencing Shed Light on Mechanisms of Treg Suppression in a Murine Model of Acute GvHD

Molecular Imaging of Chimeric Antigen Receptor T Cells By ICOS-Immunopet

Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming

iNKT Cell Stimulation with Liposomal Alpha/Gal/Cer Amplifies Proliferation of Adoptively Transferred Regulatory T Cells In Vivo and Reduces GvHD

Tracking T Cell Activation By OX40 Immuno-PET: A Novel Strategy for Imaging of Graft Versus Host Disease

Invariant Natural Killer T Cell Subsets Have Diverse Functions: iNKT2 and iNKT17 Protect from Graft-Versus-Host-Disease, Whereas iNKT1 Have Antitumor Potential

IL-2 Plus IL-15 Leads to Enhanced Ex Vivo Expansion of Human Invariant Natural Killer T Cells

Treatment of Donors with Liposomal Alpha-Galactosylceramide Results in the In Vivo Expansion of Invariant Natural Killer T Cells and Reduced Incidence of Acute Graft Versus Host Disease

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Reactive Hemophagocytic Syndrome after Hematopoietic Stem Cell Transplantation: A Multicenter Retrospective Study on Behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only